You might also like
Viemed Healthcare, Inc. (VMD) is a leading provider of home medical equipment and post-acute respiratory healthcare services in the United States. The company specializes in in-home treatment for patients suffering from respiratory diseases, offering therapy and counseling through clinical practitioners using advanced technology. VMD's offerings include ventilator rentals, other home medical equipment, medical supply sales, and healthcare staffing services, all aimed at improving patient outcomes and reducing hospital readmissions.
- Ventilator Rentals - Provides non-invasive and invasive ventilators for patients with respiratory diseases, ensuring high-quality in-home care through licensed respiratory therapists.
- Other Home Medical Equipment (HME) Rentals - Offers equipment such as Positive Airway Pressure (PAP) therapy devices, oxygen therapy equipment, and percussion vests to support various respiratory and sleep-related conditions.
- Equipment and Supply Sales - Sells medical equipment and supplies, including products for PAP therapy and other sleep-related treatments, driven by the success of its resupply programs.
- Service Revenues - Provides healthcare staffing services and workforce solutions to external healthcare institutions, addressing the demand for qualified clinical professionals.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Casey Hoyt ExecutiveBoard | Chief Executive Officer | AA Homecare Board of Directors; Ochsner Lafayette General Foundation Board; Ochsner Lafayette General Foundation Board of Trustees; Community Foundation of Acadiana Board of Directors | Casey Hoyt has served as the Chief Executive Officer of Viemed Healthcare, Inc. since December 2017 and as a Director since December 14, 2016, playing a pivotal role in driving innovative respiratory disease management solutions. Previously, he co-founded Sleep Management, L.L.C. and Home Sleep Delivered, L.L.C. in 2006 and served as CEO at Protech Home Medical Corp. until the spin-out in December 2017. | View Report → |
Dr. William Frazier ExecutiveBoard | Chief Medical Officer | Dr. William Frazier has served as the Chief Medical Officer of VMD since December 21, 2017 and as a member of the Board of Directors (since December 21, 2017), providing over 30 years of expertise in pulmonary medicine. Previously, he served as Chief Medical Officer at PHM and for the Sleepco Subsidiaries beginning in October 2015. | View Report → | |
W. Todd Zehnder ExecutiveBoard | Chief Operating Officer (COO) | W. Todd Zehnder is the Chief Operating Officer (COO) and Director at VMD since December 21, 2017, contributing to both operational management and governance; he previously served as VP - Finance and Chief Strategy Officer at PHM from December 2015 to December 2017 and held executive roles at PetroQuest Energy Inc. from 2008 to December 2015. | View Report → | |
Jeremy Trahan Executive | General Counsel and Corporate Secretary | Jeremy Trahan has been serving as the General Counsel and Corporate Secretary of VMD since May 2024, and previously served as Chief Legal Officer from August 2022 to May 2024. | View Report → | |
Jerome Cambre Executive | Vice President of Sales | Jerome Cambre is the Vice President of Sales at VMD since March 2018. He previously held roles including National Sales Trainer (March 2017 to March 2018), Director of Clinical Sales (March 2016 to March 2017), Patient Care Coordinator (October 2015 to 2016), and Sales Representative (starting November 2013). | View Report → | |
Michael Moore Executive | President | Michael Moore has served as the President of Viemed Healthcare, Inc. since December 2017. Previously, he held key executive roles including Managing Director, Disease Management at PHM from May 2015 to December 2017, President of PHM starting May 2015, and Interim CFO of PHM starting March 2016. | View Report → | |
Trae Fitzgerald Executive | Chief Financial Officer (CFO) | Trae Fitzgerald serves as the Chief Financial Officer (CFO) at Viemed Healthcare, Inc., responsible for certifying financial reports and ensuring regulatory compliance. There is no detailed career history or information regarding previous roles provided in the documents. | View Report → | |
Nitin Kaushal Board | Director | High Tide Inc.; Everyday People Financial Corp.; Synergy CHC Corp. | Nitin Kaushal has served as a director at VMD since December 2017. He also serves as the Chairman of the Audit Committee and as a member of the Corporate Governance & Nominating Committee, leveraging his extensive financial and governance expertise. | |
Randy Dobbs Board | Chairman of the Board | Chairman of EnableComp | Randy Dobbs has served as the Chairman of the Board at VMD since December 2017 and also sits on its Audit and Compensation Committees. He brings extensive governance expertise from his previous roles, including his current position as Chairman at EnableComp. | |
Sabrina Heltz Board | Director | Senior Healthcare Advisor at Rule of Three | Sabrina Heltz has been serving as Director at Viemed Healthcare, Inc. since November 4, 2020. She brings extensive healthcare leadership experience from her previous roles at BCBSLA, Ochsner Health Network, and is currently a Senior Healthcare Advisor at Rule of Three since July 2023. | |
Timothy Smokoff Board | Director | Acting-CEO and Board Member at PolyVascular, LLC ; General Manager, Home Health & Hospice Division at Resmed ; Board Member at Total Triage Holdings, LLC | Timothy Smokoff has served as Director at VMD since December 21, 2017. He also serves as Chairman of the Compensation Committee and as a member of the Corporate Governance & Nominating Committee, leveraging extensive experience in the health industry. |
- Given the marked discrepancy between your sleep therapy patient count and resupply orders, can you clarify how you plan to integrate these figures to ensure consistent revenue growth and margin protection as the sleep business expands? [Index 7][Index 8]
- With the significant restructuring of your sales force resulting in notable increases in vent patient additions, what specific performance metrics will you use to ensure that these gains translate into sustainable long-term productivity improvements? [Index 9]
- In light of the ongoing regulatory discussions around the 75-25 reimbursement relief, can you provide a detailed update on your expectations for recapturing these funds and how any delay might impact your near-term projections? [Index 2]
- Regarding your increased CapEx tied to the replacement of Philips' recalled ventilators, what are your plans and timelines for fully remediating the vent fleet, and how might uncertainty around Philips’ decisions affect your cash flow planning? [Index 12]
- On the M&A front, you mentioned a robust pipeline with potential deals around the $25–30 million range; could you elaborate on your criteria for evaluating these opportunities and the integration challenges you anticipate, especially amid efforts to diversify beyond respiratory products? [Index 10]
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
Lehan Drugs, Inc. | 2025 | Viemed Healthcare will acquire Lehan for a base purchase price of $26 million plus $2.2 million in estimated contingent payments, with funding through cash on hand and existing credit facilities, and an expected closing in Q3 2025. The acquisition strengthens Viemed’s diversification strategy by adding key capabilities in home medical equipment, respiratory care, and maternal health, while integrating over 90 employees and established locations in Northern Illinois and West Chicagoland. |
East Alabama HomeMed, LLC | 2024 | Viemed Healthcare acquired a controlling 60% interest in HomeMed on April 1, 2024, recognizing $3.2 million in goodwill, a $0.4 million trade name, and a $1.8 million noncontrolling interest, with incremental annualized revenue expected around $4 million, funded via the 2022 Revolving Credit Facility. The strategic partnership with East Alabama Health enhances Viemed’s growth via geographic and product diversification along with opportunities for hospital joint ventures and referral synergies. |
Home Medical Products, Inc. (HMP) | 2023 | Viemed Healthcare completed the HMP acquisition on June 1, 2023, for approximately $28–29.4 million using a mix of cash and borrowings, adding significant geographic coverage across Tennessee, northern Alabama, and northern Mississippi and achieving greater operational synergies with about 40,000–45,000 active patients and robust revenue/EBITDA profiles. This move strategically diversifies its respiratory care and home medical equipment offerings, with notable integration costs and goodwill of $29.7 million and a termination clause if not closed by August 1, 2023. |
Recent press releases and 8-K filings for VMD.
- Strong Q1 performance driven by organic revenue growth across core vent, sleep, staffing, and oxygen businesses, with notable improvements in adjusted EBITDA margins.
- Updated guidance for full year 2025, raising the bottom end of net revenue and adjusted EBITDA ranges based on the robust Q1 results.
- Strategic acquisition of Lehan's Medical Equipment for $26 million is pending in Q3 2025, aiming to expand into maternal and enhanced respiratory care markets.
- Regulatory developments including CMS's proposed NCD on noninvasive positive pressure ventilation underscore a favorable environment for the company.